COMPARISON OF CONCENTRATIONS OF 2 DOSES OF CLAVULANIC ACID (200 AND 400 MILLIGRAMS) ADMINISTERED WITH AMOXICILLIN (2,000 MILLIGRAMS) IN TISSUES OF PATIENTS UNDERGOING COLORECTAL SURGERY
C. Martin et al., COMPARISON OF CONCENTRATIONS OF 2 DOSES OF CLAVULANIC ACID (200 AND 400 MILLIGRAMS) ADMINISTERED WITH AMOXICILLIN (2,000 MILLIGRAMS) IN TISSUES OF PATIENTS UNDERGOING COLORECTAL SURGERY, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 94-98
The concentrations of clavulanic acid and amoxicillin were determined
in sera and different abdominal tissues of 17 patients who underwent e
lective colorectal surgery. Patients were randomly allocated to two gr
oups. At the time of induction of anesthesia, patients in group 1 were
given 200 mg of clavulanic acid with 2,000 mg of amoxicillin and pati
ents in group 2 received 400 mg of clavulanic acid with 2,000 mg of am
oxicillin. In both groups, the initial dose was administered again aft
er 2 h. Blood samples were collected to determine peak and trough anti
biotic levels. Serial blood samples were also collected at predetermin
ed periods (opening and closure of the abdominal cavity and surgical a
nastomosis). Abdominal wall fat, epiploic fat, and colonic wall tissue
samples were collected simultaneously, Antibiotic concentrations were
determined hy high-performance liquid chromatography. Increasing the
dose of clavulanic acid to 400 mg resulted in significantly higher pea
k and trough levels in serum (P < 0.03). Following the injection of 40
0 mg, mean concentrations of clavulanic acid in the fatty tissues were
significantly increased at the time of opening (P < 0.02). The concen
trations of clavulanic acid and amoxicillin in fatty tissues were 17 t
o 52% and 12, to 23% of the levels in sera, respectively. In the colon
ic wall, the concentrations of clavulanic acid and amoxicillin were 52
to 63% and 49 and 27% of the levels in sera, respectively. In sera, c
lavulanic acid given at a dose of 200 or 400 mg reached or exceeded th
e concentrations found to be effective in vitro to reduce the MICs of
amoxicillin from the resistant to the susceptible category for 90% of
the potential pathogens. In most of the tissues investigated, increasi
ng the dose of clavulanic acid to 400 mg resulted in a significantly h
igher number of samples with concentrations found to be effective in v
itro (72 versus 11%; P < 0.05). In conclusion, increasing the dose of
clavulanic acid to 400 mg resulted in higher levels in sera and improv
ed penetration into the abdominal tissues in patients undergoing color
ectal surgery.